跳至主要内容
临床试验/NCT07634068
NCT07634068尚未招募2 期

Vertebrobasilar Dolichoectasia Treatment With Amiloride: a Pilot Study Based On 5.0 T MRI

Huashan Hospital1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2026年6月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
6
试验地点
1

研究概览

简要总结

The aim of this pilot study is to assess the efficacy of amiloride in reducing wall enhancement in vertebrobasilar dolichoectasia(VBD) on high-resolution magnetic resonance vessel wall imaging(HR-VWI) via anti-inflammatory mechanisms, clarify the efficacy of amiloride in delaying the progression of VBD, evaluate the safety of amiloride in the treatment of VBD.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age≥18 years, any gender;
  • Patients with VBD confirmed by DSA/CTA/MRA;
  • No history of VBD rupture and no surgical treatment for VBD;
  • Positive plasma SGK1;
  • No history of posterior circulation stroke, and no symptoms or signs related to VBD;
  • No need for subsequent use of antiplatelet or statin drugs;
  • Capable of signing an informed consent form with the accompaniment and understanding of a guardian.

排除标准

  • History of malignant tumors, systemic lupus erythematosus, or gout;
  • Pregnancy or lactation;
  • Amiloride or sulfonamide allergy;
  • Hydrocephalus requiring urgent surgical intervention or respiratory failure requiring life support treatment;
  • Abnormal hepatic and/or renal function (serum transaminase > 40 U/L; serum creatinine > 110 μmol/L); and/or abnormal white blood cells/platelets (white blood cells count < 3.5 × 10⁹/L or > 9.5 × 10⁹/L; platelets count < 100 × 10⁹/L or > 300 × 10⁹/L); hyperkalemia, hypokalemia, hyponatremia, or hypercalcemia;
  • Acute cerebral infarction within the last month or definite high signal on DWI indicating acute or subacute cerebral infarction;
  • Acute stage of intracranial hemorrhage as indicated by CT;
  • History of VBD rupture or surgery;
  • Presence of acute active infection (such as severe bacterial, viral or fungal infection);
  • Uncontrolled diabetes (HbA1c≥7%);
  • Need for subsequent use of antiplatelet or statin drugs;
  • Systolic blood pressure< 90 mmHg or/and diastolic blood pressure< 60 mmHg;
  • Currently participating in other clinical studies;
  • Presence of contraindications for MRI examination;
  • Other situations not suitable for inclusion.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wei Zhu

Principal Investigator

Huashan Hospital

研究点 (1)

Loading locations...

相似试验